Pregled bibliografske jedinice broj: 101545
Maximal androgen blockade and neuroendocrine differentiation in prostate cancer patients.
Maximal androgen blockade and neuroendocrine differentiation in prostate cancer patients. // Book of Abstracts, 4th World Congress of Urological Research. / Kiprianou, Natasha et all. (ur.).
Iowa City (IA): Society for Basic Urological Research, 2001. str. 52-52 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 101545 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Maximal androgen blockade and neuroendocrine differentiation in prostate cancer patients.
Autori
Tarle, Marko ; Ahel, Zaky ; Spajić, Borislav ; Reljić, Ante ; Kraljić, Ivo ; Kovačić, Ksenija.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Book of Abstracts, 4th World Congress of Urological Research.
/ Kiprianou, Natasha et all. - Iowa City (IA) : Society for Basic Urological Research, 2001, 52-52
Skup
4th World Congress in Urological Research
Mjesto i datum
Tucson (AZ), Sjedinjene Američke Države, 29.11.2001. - 02.12.2001
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
prostate cancer; Mab; NE differentiation; CgA level
Sažetak
The acquired CgA positivity is more pronounced with the prolonged hormonal treatment and is frequently related to the development of bone lesions. Thus during Mab continous serum CgA monitoring should be performed. These data raised the question related to the utility of intermittent prostate cancer hormonal therapy.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
